2011
Irwin, Ronald W, et al. “Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease.”. Front Endocrinol (Lausanne), vol. 2, Jan. 2011, p. 117, https://doi.org/10.3389/fendo.2011.00117.
Hanlon, Katherine E, et al. “Novel Peptide Ligands With Dual Acting Pharmacophores Designed for the Pathophysiology of Neuropathic Pain.”. Brain Res, vol. 1395, Jan. 2011, pp. 1-11, https://doi.org/10.1016/j.brainres.2011.04.024.
Vardanyan, Ruben, et al. “Synthesis and Biological Evaluation of New Opioid Agonist and Neurokinin-1 Antagonist Bivalent Ligands.”. Bioorg Med Chem, vol. 19, no. 20, Jan. 2011, pp. 6135-42, https://doi.org/10.1016/j.bmc.2011.08.027.
Yao, Jia, and Brinton, Roberta Diaz. “Targeting Mitochondrial Bioenergetics for Alzheimer’s Prevention and Treatment.”. Curr Pharm Des, vol. 17, no. 31, Jan. 2011, pp. 3474-9.
Rettberg, Jamaica R, et al. “The Effect of Dietary Soy Isoflavones before and After Ovariectomy on Hippocampal Protein Markers of Mitochondrial Bioenergetics and Antioxidant Activity in Female Monkeys.”. Brain Res, vol. 1379, Jan. 2011, pp. 23-33, https://doi.org/10.1016/j.brainres.2011.01.012.
2010
Largent-Milnes, T M, et al. “Spinal or Systemic TY005, a Peptidic Opioid Agonist Neurokinin 1 Antagonist, Attenuates Pain With Reduced Tolerance.”. Br J Pharmacol, vol. 161, no. 5, Nov. 2010, pp. 986-1001, https://doi.org/10.1111/j.1476-5381.2010.00824.x.
Yao, Jia, et al. “Decline in Mitochondrial Bioenergetics and Shift to Ketogenic Profile in Brain During Reproductive Senescence.”. Biochim Biophys Acta, vol. 1800, no. 10, Oct. 2010, pp. 1121-6, https://doi.org/10.1016/j.bbagen.2010.06.002.
Lochhead, Jeffrey J, et al. “Oxidative Stress Increases Blood-Brain Barrier Permeability and Induces Alterations in Occludin During Hypoxia-Reoxygenation.”. J Cereb Blood Flow Metab, vol. 30, no. 9, Sept. 2010, pp. 1625-36, https://doi.org/10.1038/jcbfm.2010.29.
Tumati, S, et al. “Sustained Morphine-Mediated Pain Sensitization and Antinociceptive Tolerance Are Blocked by Intrathecal Treatment With Raf-1-Selective SiRNA.”. Br J Pharmacol, vol. 161, no. 1, Sept. 2010, pp. 51-64, https://doi.org/10.1111/j.1476-5381.2010.00869.x.
Papanicolaou, Kyriakos N, et al. “Preserved Heart Function and Maintained Response to Cardiac Stresses in a Genetic Model of Cardiomyocyte-Targeted Deficiency of Cyclooxygenase-2.”. J Mol Cell Cardiol, vol. 49, no. 2, Aug. 2010, pp. 196-09, https://doi.org/10.1016/j.yjmcc.2010.04.002.
Largent-Milnes, Tally M, and Vanderah, Todd W. “Recently Patented and Promising ORL-1 Ligands: Where Have We Been and Where Are We Going?”. Expert Opin Ther Pat, vol. 20, no. 3, Mar. 2010, pp. 291-05, https://doi.org/10.1517/13543771003602004.
Lozano-Ondoua, Alysia N, et al. “A Cannabinoid 2 Receptor Agonist Attenuates Bone Cancer-Induced Pain and Bone Loss.”. Life Sci, vol. 86, no. 17-18, Jan. 2010, pp. 646-53, https://doi.org/10.1016/j.lfs.2010.02.014.
Streicher, John M, et al. “MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart.”. Circ Res, vol. 106, no. 8, Jan. 2010, pp. 1434-43, https://doi.org/10.1161/CIRCRESAHA.109.213199.
Henderson, Victor W, and Brinton, Roberta Diaz. “Menopause and Mitochondria: Windows into Estrogen Effects on Alzheimer’s Disease Risk and Therapy.”. Prog Brain Res, vol. 182, Jan. 2010, pp. 77-96, https://doi.org/10.1016/S0079-6123(10)82003-5.
2009
Asthana, Sanjay, et al. “Frontiers Proposal. National Institute on Aging "bench to Bedside: Estrogen As a Case Study".”. Age (Dordr), vol. 31, no. 3, Sept. 2009, pp. 199-10, https://doi.org/10.1007/s11357-009-9087-2.
McCaffrey, Gwen, et al. “Occludin Oligomeric Assemblies at Tight Junctions of the Blood-Brain Barrier Are Altered by Hypoxia and Reoxygenation Stress.”. J Neurochem, vol. 110, no. 1, July 2009, pp. 58-71, https://doi.org/10.1111/j.1471-4159.2009.06113.x.
Liu, Lifei, et al. “Progesterone Increases Rat Neural Progenitor Cell Cycle Gene Expression and Proliferation via Extracellularly Regulated Kinase and Progesterone Receptor Membrane Components 1 and 2.”. Endocrinology, vol. 150, no. 7, July 2009, pp. 3186-96, https://doi.org/10.1210/en.2008-1447.
Brinton, Roberta Diaz. “Estrogen-Induced Plasticity from Cells to Circuits: Predictions for Cognitive Function.”. Trends Pharmacol Sci, vol. 30, no. 4, Apr. 2009, pp. 212-22, https://doi.org/10.1016/j.tips.2008.12.006.
Dvorak, Katerina, et al. “Expression of Bile Acid Transporting Proteins in Barrett’s Esophagus and Esophageal Adenocarcinoma.”. Am J Gastroenterol, vol. 104, no. 2, Feb. 2009, pp. 302-9, https://doi.org/10.1038/ajg.2008.85.
Yao, Jia, et al. “Mitochondrial Bioenergetic Deficit Precedes Alzheimer’s Pathology in Female Mouse Model of Alzheimer’s Disease.”. Proc Natl Acad Sci U S A, vol. 106, no. 34, Jan. 2009, pp. 14670-5, https://doi.org/10.1073/pnas.0903563106.
Nair, Padma, et al. “Novel Bifunctional Peptides As Opioid Agonists and NK-1 Antagonists”. Adv Exp Med Biol, vol. 611, Jan. 2009, pp. 537-8.
2008
Foy, Michael R, et al. “Estrogen and Hippocampal Plasticity in Rodent Models.”. J Alzheimers Dis, vol. 15, no. 4, Dec. 2008, pp. 589-03.
Brinton, Roberta Diaz. “The Healthy Cell Bias of Estrogen Action: Mitochondrial Bioenergetics and Neurological Implications.”. Trends Neurosci, vol. 31, no. 10, Oct. 2008, pp. 529-37, https://doi.org/10.1016/j.tins.2008.07.003.
Largent-Milnes, Tally M, et al. “Oxycodone Plus Ultra-Low-Dose Naltrexone Attenuates Neuropathic Pain and Associated Mu-Opioid Receptor-Gs Coupling.”. J Pain, vol. 9, no. 8, Aug. 2008, pp. 700-13, https://doi.org/10.1016/j.jpain.2008.03.005.
Irwin, Ronald W, et al. “Progesterone and Estrogen Regulate Oxidative Metabolism in Brain Mitochondria.”. Endocrinology, vol. 149, no. 6, June 2008, pp. 3167-75, https://doi.org/10.1210/en.2007-1227.